Status:

COMPLETED

Chronic HIV Infection and Aging in NeuroAIDS (CHAIN)

Lead Sponsor:

University of Nebraska

Collaborating Sponsors:

National Institute of Mental Health (NIMH)

Conditions:

HIV

Aging

Eligibility:

All Genders

20-75 years

Brief Summary

The purpose of this study is to find the best tests to use to investigate the differences between older and younger people with HIV disease. Test to be included will measures of memory, learning, acti...

Detailed Description

Advances in the treatment of chronic HIV disease over the last 20 years have resulted in dramatic declines in morbidity and mortality. However, emerging data suggest that chronically infected patients...

Eligibility Criteria

Inclusion

  • Diagnosed with HIV infection.
  • 20-40 years of age or older than 50.
  • If taking antiretroviral therapy, on stable therapy for the past 12 weeks and not anticipated to require a change in therapy during the following 6 weeks.
  • If not taking antiretroviral therapy, not anticipated to initiate therapy in the next 6 weeks.
  • Ability to provide written informed consent.
  • Ability to complete the questionnaires in English.

Exclusion

  • Completion of treatment for any intercurrent acute infection less than four weeks before study entry. Maintenance or prophylactic therapy is permitted for opportunistic infections.
  • Any active psychiatric illness including schizophrenia, severe depression, or severe bipolar affective disorder that, in the opinion of the investigator, could confound performance of or the analysis of the test results.
  • Active drug or alcohol abuse that, in the investigator's opinion, could compromise compliance with study procedures or confound the analysis of the test results.
  • Major neurologic disease such as multiple sclerosis or stroke, active brain infection (except for HIV-1), brain neoplasm, or space-occupying brain lesion.
  • Current delirium or intoxication.
  • Pregnancy.
  • Any other condition that, in the opinion of the investigator, is a contraindication to participation.

Key Trial Info

Start Date :

August 1 2010

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

December 17 2014

Estimated Enrollment :

21 Patients enrolled

Trial Details

Trial ID

NCT01186042

Start Date

August 1 2010

End Date

December 17 2014

Last Update

September 6 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Nebraska Medical Center

Omaha, Nebraska, United States, 68198